Helen Lalou-Balogun
Trial Nurse
Recent publications
-
T cell renaissance in COVID-19
Journal article
Garner L. and Cifuentes L., (2020), Nature Reviews Immunology, 20
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Journal article
Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478
-
Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
Journal article
Chen YL. et al, (2019), Science Translational Medicine, 11
-
First-in-class phase 2a study of anb020 (anti-il-33) in the treatment of moderate-to-severe atopic dermatitis
Conference paper
Chen Y. et al, (2018), ALLERGY, 73, 77 - 77
-
Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo
Journal article
Gilles-Stein S. et al, (2016), Clinical and Experimental Allergy, 46, 1355 - 1365